Remove 2023 Remove Conditions Remove Medical Evaluation
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

A 2023 study in Cannabis and Cannabinoid Research validated this approach, showing that patients following slower titration schedules had 84% treatment satisfaction compared to 61% with faster increases. The Stanford Sleep Laboratory Findings Stanford’s Sleep Research Center studied 847 insomnia patients using different cannabis doses.

article thumbnail

DEA Pushes Marijuana Rescheduling Hearing To December: What Does This Mean For Cannabis?

Veriheal

Because the categorization of a controlled substance determines its availability and accessibility, the benefits of rescheduling are important to patients suffering from chronic pain, epilepsy, and other conditions. In August 2023, the HHS also crucially recommended to the DEA that cannabis be relisted from Schedule I to Schedule III.

DEA 97